艾氯胺酮鼻腔喷雾剂获批用于治疗难治性抑郁症。 - Suppr

Esketamine nasal spray approved for treatment-resistant depression.

作者信息

Traynor Kate

出版信息

Am J Health Syst Pharm. 2019 Apr 17;76(9):573. doi: 10.1093/ajhp/zxz065.

DOI:10.1093/ajhp/zxz065

PMID:31361833

Abstract

摘要

相似文献

Esketamine nasal spray approved for treatment-resistant depression.

Am J Health Syst Pharm. 2019 Apr 17;76(9):573. doi: 10.1093/ajhp/zxz065.

Esketamine Nasal Spray Effective in Treatment-Resistant Depression.

JAMA. 2019 Jul 23;322(4):296. doi: 10.1001/jama.2019.10368.

Esketamine counters opioid-induced respiratory depression.

Br J Anaesth. 2018 May;120(5):1117-1127. doi: 10.1016/j.bja.2018.02.021. Epub 2018 Mar 26.

Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review.

CNS Drugs. 2018 May;32(5):411-420. doi: 10.1007/s40263-018-0519-3.

Challenges for esketamine nasal spray in China: use and management.

Front Pharmacol. 2024 Oct 1;15:1429435. doi: 10.3389/fphar.2024.1429435. eCollection 2024.

Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.

N Engl J Med. 2019 Jul 4;381(1):1-4. doi: 10.1056/NEJMp1903305. Epub 2019 May 22.

Sedation with propofol during ERCP: is the combination with esketamine more effective and safer than with alfentanil? Study protocol for a randomized controlled trial.

Trials. 2017 Oct 11;18(1):472. doi: 10.1186/s13063-017-2197-8.

The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.

Psychopharmacology (Berl). 2017 Nov;234(21):3175-3183. doi: 10.1007/s00213-017-4706-6. Epub 2017 Jul 28.

Mometasone furoate nasal spray for nasal polyposis.

Expert Rev Respir Med. 2007 Oct;1(2):187-96. doi: 10.1586/17476348.1.2.187.

Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.

Expert Opin Pharmacother. 2010 Jun;11(9):1559-67. doi: 10.1517/14656566.2010.485609.

引用本文的文献

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review.

Pharmaceutics. 2023 Dec 13;15(12):2773. doi: 10.3390/pharmaceutics15122773.

Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression.

Transl Psychiatry. 2021 Nov 25;11(1):598. doi: 10.1038/s41398-021-01716-w.

Enantioselectivity in Drug Pharmacokinetics and Toxicity: Pharmacological Relevance and Analytical Methods.

Molecules. 2021 May 23;26(11):3113. doi: 10.3390/molecules26113113.

Imaging of intranasal drug delivery to the brain.

Am J Nucl Med Mol Imaging. 2020 Feb 25;10(1):1-31. eCollection 2020.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Esketamine nasal spray approved for treatment-resistant depression.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献